Bimodal regulation of FoxO3 by AKT and 14-3-3

Melissa Dobson1, Gopalakrishnan Ramakrishnan, Stephanie Ma

  • 1Karmanos Cancer Institute and Department of Pathology, Wayne State University, Detroit, MI 48201, USA.

Insights

The AKT-FoxO3 interaction and 14-3-3 binding stabilize FoxO3 protein levels. 14-3-3 binding, not AKT phosphorylation, controls FoxO3 activity, influencing its fate.

Area of Science:

  • Molecular Biology
  • Cellular Signaling

Background:

  • Forkhead box O 3 (FoxO3) is a transcription factor regulated by AKT signaling.
  • AKT phosphorylates FoxO3, creating binding sites for 14-3-3 proteins, which impacts FoxO3 activity and localization.

Purpose of the Study:

  • To investigate the functional significance of the AKT-FoxO3 interaction.
  • To elucidate the mechanistic regulation of FoxO3 by AKT and 14-3-3.

Main Methods:

  • Overexpression of AKT and characterization of its interaction with FoxO3.
  • Site-directed mutagenesis to create a FoxO3 mutant deficient in 14-3-3 binding (P34A).
  • Analysis of FoxO3 protein levels, phosphorylation, transcriptional activity, and degradation rates.

Main Results:

  • AKT overexpression increases FoxO3 protein levels, dependent on AKT activity and binding to FoxO3.
  • AKT binds FoxO3 independently of phosphorylation motifs, suggesting a distinct docking site.
  • 14-3-3 binding, not AKT phosphorylation, is critical for controlling FoxO3 transcriptional activity.
  • 14-3-3 binding stabilizes FoxO3 by reducing dephosphorylation and degradation.

Conclusions:

  • Both AKT and 14-3-3 positively regulate FoxO3, contrary to established negative roles.
  • 14-3-3 availability determines whether phosphorylated FoxO3 undergoes degradation or recycling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...